Frequently Asked Questions About the LIFE-BTK PK SUB-STUDY

Can I still enroll in the LIFE-BTK study?

No. Patient enrollment is closed for both LIFE-BTK and LIFE-BTK PK SUB‑STUDY.

What treatment is being tested in the LIFE-BTK PK SUB-STUDY?

This is a study to test the Esprit™ BTK resorbable scaffold, a new device for the treatment of CLI. The device is implanted in the artery immediately after a balloon angioplasty, providing support and preventing the vessel from reclosing. The scaffold releases a drug into the artery over a few months that promotes healing and keeps the artery open. The device is made of a material that dissolves over time and will be gone from your body in about 3 years.

How long is participation in the LIFE-BTK PK SUB-STUDY?

Patients in this study will have multiple visits over 5 years.

How many participants are being enrolled in the LIFE-BTK PK SUB-STUDY?

The LIFE-BTK PK SUB-STUDY will evaluate 9 patients from around the world.

What are the benefits of participating in a clinical study?

Clinical studies are very important to advancing medicine and can help others lead healthier lives. Some people join a study because the treatments they have tried for their health problem did not work or because there is no treatment available. By being part of a clinical trial, participants may gain access to new treatments before they are widely available.

For full site functionality you must enable functional and advertising cookies.

This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We may also share information about your use of our site with our social media, advertising and analytics partners. For more information about how Abbott uses cookies please see our Cookie Policy and Privacy Policy.

In order to accept functional and advertising cookies, please click "Enable Cookies" and then click "Accept Sale/Sharing and Targeted Advertising" to view the full site.